中粮生物科技股份有限公司2025年半年度报告摘要

Group 1 - The company did not distribute cash dividends or issue bonus shares during the reporting period [3] - The company reported no changes in its controlling shareholder or actual controller during the reporting period [5][6] - The board of directors approved the 2025 semi-annual report and its summary with unanimous consent [9] Group 2 - The company plans to hold the 2025 Fourth Extraordinary General Meeting on September 8, 2025, with both on-site and online voting options available [26][27] - The company will provide a network voting platform for shareholders to exercise their voting rights during the specified voting times [28][30] - The company will separately count and disclose the voting results of minority investors [31] Group 3 - The company has proposed to appoint Guo Fei as a non-independent director candidate following the resignation of Zhang Hongfei due to work reasons [21][23] - The company has conducted a comprehensive review of its financial situation and has proposed to recognize asset impairment losses in accordance with accounting standards [10][19] - The company’s supervisory board confirmed that the semi-annual report and the asset impairment preparation proposal complied with relevant regulations and accurately reflected the company's financial status [18][19]